PPP3R1

PPP3R1 (calcineurin B, CnB1) is the obligate Ca2+-binding regulatory subunit of the calcineurin protein phosphatase heterodimer, and its binding to the catalytic A subunit is required for full phosphatase activity (PMID:1321337, PMID:8978785). Activation is transmitted through a salt bridge between Lys134 of CnB1 and Glu53 of the catalytic subunit; disrupting either residue destabilizes the compact A–B association and impairs phosphatase activation (PMID:15527802). Through calcineurin, PPP3R1 supports transcriptional programs including NF-AT-dependent IL-2 expression in T lymphocytes (PMID:8978785) and is required in vivo for cardiac morphogenesis, contractility, postnatal cardiomyocyte proliferation, and expression of Ca2+-handling genes (PMID:20037164). An EF-hand 3 variant (p.D102A) that reduces CnB1 binding to the catalytic subunit and lowers phosphatase activity causes dilated cardiomyopathy, establishing a loss-of-function disease mechanism (PMID:32882262). Beyond its scaffolding role within calcineurin, PPP3R1 acts as an extracellular ligand: it binds integrin αM on macrophages with high affinity to drive TRAIL expression and tumoricidal activity (PMID:22116828), and it is an endogenous ligand of the TLR4/MD2/CD14 complex, taken up by clathrin-dependent endocytosis in competition with LPS (PMID:27090571). In mesenchymal stem cells, PPP3R1 accelerates senescence by depolarizing the plasma membrane and increasing Ca2+ influx to activate NFAT/ATF3/p53 signaling, shifting differentiation toward adipogenesis (PMID:36901851). The conserved fission yeast ortholog Cnb1 partners with the catalytic subunit Ppb1 at the contractile ring and is required for septal maturation and cytokinesis (PMID:23956092).

1. 1992 High

   Established that the calcineurin B subunit is functionally required for phosphatase activity rather than a dispensable accessory, answering whether the catalytic subunit alone suffices.

   Evidence Biochemical purification and calcineurin activity assay in cnb1Δ yeast extracts, with Ca2+-binding assay and gene cloning

   PMID:1321337

   Open questions at the time

   • Did not resolve the structural basis of B-subunit activation
   • Human PPP3R1 not directly tested in this study
2. 1996 Medium

   Localized the human gene to chromosome 2p16→p15 and framed its product as the 19 kDa Ca2+-binding regulatory subunit acting in NF-AT/IL-2 transcriptional control, anchoring CnB1 in human immune signaling.

   Evidence Chromosomal mapping by somatic cell hybrid and FISH

   PMID:8978785

   Open questions at the time

   • No direct functional assay of human protein here
   • Single mapping method, single lab
3. 2004 Medium

   Identified the specific molecular contact (CnB Lys134–CnA Glu53 salt bridge) that transmits the activating effect of B-subunit binding, explaining how regulatory binding becomes catalytic activation.

   Evidence Site-directed mutagenesis with phosphatase activity assays and structural analysis

   PMID:15527802

   Open questions at the time

   • Mechanism of Ca2+-triggered conformational coupling not fully resolved
   • Single-lab biochemistry
4. 2008 Medium

   Raised the possibility of a calcineurin-phosphatase-independent function by showing CnB overexpression drives proliferation, anchorage-independent growth, and migration without altering phosphatase activity.

   Evidence Stable transfection in HEK293 with proliferation, soft agar, migration and activity assays plus proteomics (HSP27, DJ-1)

   PMID:18422742

   Open questions at the time

   • Molecular effector of the phosphatase-independent activity not defined
   • Overexpression-based, single cell line
5. 2009 High

   Demonstrated an essential in vivo requirement for CnB1 in cardiac development and function, linking the subunit to morphogenesis, contractility, and Ca2+-handling gene expression.

   Evidence Cardiomyocyte-specific conditional knockout (Nkx2.5-Cre and αMHC-Cre) with echocardiography, telemetry, histology and gene expression analysis

   PMID:20037164

   Open questions at the time

   • Did not separate phosphatase-dependent from independent contributions in heart
   • Direct transcriptional targets driving Ca2+-handling gene loss not mapped
6. 2011 High

   Revealed an unexpected extracellular role: CnB functions as a high-affinity ligand of macrophage integrin αM to induce TRAIL and tumoricidal activity, extending CnB1 beyond intracellular scaffolding.

   Evidence Radioligand and affinity-pulldown binding assays, MS identification, antibody blocking, RNAi, and an in vivo tumor model

   PMID:22116828

   Open questions at the time

   • Source of extracellular CnB in vivo unclear
   • Signaling between integrin αM and TRAIL induction not fully mapped
7. 2013 Medium

   Showed conservation of the calcineurin complex role in cytokinesis by demonstrating the fission yeast ortholog Cnb1 acts with Ppb1 at the contractile ring for septal maturation and septin ring stability.

   Evidence Deletion mutant analysis, fluorescence colocalization, cytokinesis and septin localization assays in S. pombe

   PMID:23956092

   Open questions at the time

   • Mechanism of post-transcriptional septin mislocalization undefined
   • Relevance to mammalian cytokinesis not tested
8. 2013 Medium

   Identified PPP3R1 as a direct target of placenta-specific miR-512-3p, placing the subunit under post-transcriptional regulatory control.

   Evidence Microarray, qRT-PCR, Western blot and 3'-UTR luciferase reporter assay in BeWo trophoblasts

   PMID:24246042

   Open questions at the time

   • Physiological consequence of CnB1 downregulation in placenta not established
   • Single cell model
9. 2016 Medium

   Established CnB as an endogenous ligand of the TLR4/MD2/CD14 complex internalized by clathrin-dependent endocytosis, distinguishing it from LPS while competing for the same receptor.

   Evidence Cellular uptake assays, clathrin inhibition, receptor knockdown/blocking, MST binding, and LPS competition

   PMID:27090571

   Open questions at the time

   • Downstream innate immune signaling outcome of CnB–TLR4 engagement not detailed
   • Single-lab characterization
10. 2018 Medium

    Added a second microRNA regulatory axis by showing miR-548a-3p directly targets PPP3R1 to promote keratinocyte proliferation, with relevance to psoriatic lesions.

    Evidence 3'-UTR luciferase reporter with mutagenesis, CCK-8 proliferation, Western blot, IHC and qRT-PCR in HaCaT cells

    PMID:29181737

    Open questions at the time

    • Causal link between PPP3R1 loss and proliferation not mechanistically dissected
    • Single cell line
11. 2020 High

    Provided causal genetic evidence that an EF-hand 3 variant (p.D102A) reducing CnA binding and phosphatase activity causes dilated cardiomyopathy, defining a loss-of-function disease mechanism.

    Evidence Whole-exome sequencing of a proband plus a knock-in mouse model with activity assay, CnB1–CnA binding assay, and echocardiography

    PMID:32882262

    Open questions at the time

    • Single family/variant
    • How reduced Ca2+ binding propagates to cardiac dysfunction not fully traced
12. 2023 Medium

    Connected PPP3R1 to cellular senescence, showing it drives MSC aging via membrane depolarization, Ca2+ influx and NFAT/ATF3/p53 activation that skews differentiation.

    Evidence Gain- and loss-of-function with membrane potential, Ca2+ influx, senescence, differentiation and pathway analyses

    PMID:36901851

    Open questions at the time

    • Mechanism by which PPP3R1 depolarizes the plasma membrane unknown
    • Single-lab model
13. 2024 Medium

    Showed transcriptional control of PPP3R1 via a promoter polymorphism (rs4519508) that disrupts E2F6 repressor binding, raising CnB1 levels and blunting tacrolimus immunosuppression.

    Evidence Dual-luciferase reporter, EMSA, E2F6 overexpression, qRT-PCR and ELISA cytokine assays

    PMID:39767802

    Open questions at the time

    • In vivo relevance to transplant pharmacology not established
    • Single-lab association

• How the intracellular phosphatase-regulatory role and the extracellular ligand role of PPP3R1 are reconciled — including the source and trafficking of extracellular CnB — remains unresolved.
• No study reconciles intracellular versus extracellular pools of CnB1
• Signaling outputs downstream of integrin αM and TLR4 engagement incompletely mapped